The effect of experimental diabetes on the circadian pattern of adenosine deaminase and myeloperoxidase activities in rat liver

General Physiology and Biophysics

Volumn 27, Issue 1, 2008, Pages 25-31

  Uluoglu, Canan ^a   Cimen, B ^b   Ozbey, G ^a   Karasu, C ^a   Durakoglugil, D B ^a   Gunes, A ^a   Turkozkan, N ^a   Zengil, H ^a  

^a GAZI UNIVERSITY   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

Adenosine deaminase; Circadian; Liver; Myeloperoxidase; Rat

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; GLYCOGEN; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL DIABETES MELLITUS; LEUKOCYTE; LIVER; LIVER BLOOD FLOW; MALE; METABOLIC PARAMETERS; NONHUMAN; OXYGEN SUPPLY; PROTEIN LOCALIZATION; RAT; STREPTOZOCIN DIABETES;

ADENOSINE DEAMINASE; ANIMALS; CIRCADIAN RHYTHM; DIABETES MELLITUS, EXPERIMENTAL; LEUKOCYTES; LIVER; MALE; PEROXIDASE; PHOTOPERIOD; RATS;

ANIMALIA; RATTUS;

EID: 43149089315     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Adams A., Harkness R. A. (1976): Adenosine deaminase activity in thymus and other human tissues. Clin. Exp. Immunol. 26, 647-649
2. Akkari R., Burbiel J. C., Hockemeyer J., Muller C. E. (2006): Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs. Curr. Top. Med. Chem. 6, 1375-1399
3. Augustin A. J., Breipohl W., Boker T., Lutz J., Spitznas M. (1993): Increased lipid peroxide levels and myeloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinopathy, Graefes Arch. Clin. Exp. Ophthalmol. 231, 647-650
4. Barlow-Walden L. R., Reiter R. J., Abe M., Pablos M., Menendez-Pelaez A., Chen L. D., Poeggeler B. (1995): Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int. 26, 497-502
5. Belanger R M., Desgagne M., Bruguerolle B. (1991): Temporal variations in microsomal lipid peroxidation and glutathione concentration in rat liver. Drug, Metab. Dispos. 19, 241-244
6. Biasucci L. M., D'Onofrio G., Liuzzo G., Zini G., Monaco C., Caligiuri G., Tommasi M., Rebuzzi A. G., Maseri A. (1996): Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J. Am. Coll. Cardiol. 27, 611-616
7. Bouma M. G., Van den Wildenberg E A., Buurman W. A. (1997): The anti-inflammatory potential of adenosine in ischemia-reperfusion injury: established and putative beneficial actions of a retaliatory metabolite. Shock 8, 313-320
8. Bruce C. R., Carey A. L., Hawley J. A., Febbraio M. A. (2003): Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 52, 2338-2345
9. Ceriello A. (2003): New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 26, 1589-1596
10. Chagoya de Sanchez V. (1995): Circadian variations of adenosine and of its metabolism. Could adenosine be a molecular oscillator for circadian rhythms? Can. J. Physiol. Pharmacol. 73, 339-355
11. Chagoya de Sanchez V., Hernandez Munoz R., Suarez J., Vidrio S., Yanez L., Diaz-Munoz M. (1993): Day-night variations of adenosine and its metabolizing enzymes in the brain cortex of the rat-possible physiological significance for the energetic homeostasis and the sleep-wake cycle. Brain Res. 612, 115-121
12. Chagoya de Sanchez V., Hernandez-Munoz R., Diaz-Munoz M., Villalobos R., Glender W., Vidrio S., Suarez J., Yanez L. (1983): Circadian variations of adenosine level in blood and liver and its possible physiological significance. Life Sci. 33, 1057-1064
13. Chagoya de Sanchez V., Hernandez-Munoz R., Sanchez L., Vidrio S., Yanez L., Suarez J. (1991): Twenty-four-hour changes of S-adenosylmethionine, S-adenosylhomocysteine adenosine and their metabolizing enzymes in rat liver; possible physiological significance in phospholipid methylation. Int. J. Biochem. 23, 1439-1443
14. Chagoya de Sanchez V., Hernandez-Munoz R., Suarez J., Vidrio S., Yanez L., Aguilar-Roblero R., Oksenberg A., Vega-Gonzalez A., Villalobos L., Rosenthal L., Fernandez-Cancino F., Drucker-Colin R., Diaz-Munoz M. (1996): Temporal variations of adenosine metabolism in human blood. Chronobiol. Int. 13, 163-177
15. Davies M. H., Bozigian H. P., Merrick B. A., Birt D. F., Schnell R. C. (1983): Circadian variations in glutathione-S-transferase and glutathione peroxidase activities in the mouse. Toxicol. Lett. 19, 23-27
16. Feldman J. M., Jackson T. B. (1974): Specificity of nucleotide-induced insulin secretion. Endocrinology 94, 388-394
17. Formento M. L., Borsa M., Zoni G. (1975): Steroidogenic effect of adenosine in the rat. Pharmacol. Res. Commun. 7, 247-257
18. Glowickj S. P., Kaplan S. D. (1955): Methods in Enzymology 2. p. 769, Academic Press, Inc., New York
19. Goldberg D. M. (1965): Serum adenosine deaminase in the differential diagnosis of jaundice. Br. Med. J. 1, 353-355
20. Hardeland R., Coto-Montes A., Poeggeler B. (2003): Circadian rhythms, oxidative stress, and antioxidative defense mechanisms. Chronobiol. Int. 20, 921-962
21. Hodoglugil U., Ongun O., Guney Z., Altan N., Zengil H. (1995): Temporal variation in hepatic superoxide dismutase activity in mice. Chronobiol. Int. 12, 152-155
22. Joost H. G., Steinfelder H. J. (1982): Modulation of insulin sensitivity by adenosine. Effects on glucose transport, lipid synthesis, and insulin receptors of the adipocyte. Mol. Pharmacol. 22, 614-618
23. Kacmaz A., User E. Y., Sehirli A. O., Tilki M., Ozkan S., Sener G. (2005): Protective effect of melatonin against ischemia/ reperfusion-induced oxidative remote organ injury in the rat. Surg. Today 35, 744-750
24. Kamalakkannan N., Stanely Mainzen Prince P. (2006): Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues. Mol. Cell. Biochem. 293, 211-219
25. Kampschmidt R. F., Upchurch H. F. (1970): Daily variation of body temperature, liver catalase activity, and plasma iron concentration in normal and tumor-bearing rats. Proc. Soc. Exp. Biol. Med. 134, 527-529
26. Karasu C., Cimen B., Ceylan-Isik A., Cumaoglu A. (2006): Tissue myeloperoxidase and adenosine deaminase activities in diabetic rats treated with stobadine and vitamin E. Diabet. Med. 23 (Suppl. 4), 482
27. Karasu C., Dewhurst M., Stevens E. J., Tomlinson D. R. (1995): Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia 38, 129-134
28. Kitoh Y., Ohmori M., Araki N., Miyashita F., Ando H., Kobayashi E., Sogawa N., Fujimura A. (2005): Dosing-time-dependent differences in lipopolysaccharide-induced liver injury in rats. Chronobiol. Int. 22, 987-996
29. Lemmer B. (1989): Chronopharmacology: Cellular and Biochemical Interactions. pp. 655-683, Marcel Dekker, Inc., New York
30. Li X. J. (1992): Supersensitivity of isolated atria from diabetic rats to adenosine and methacholine: modulation by pertussis toxin. J. Pharm. Pharmacol. 44, 142-144
31. Linden J. (2005): Adenosine in tissue protection and tissue regeneration. Mol. Pharmacol. 67, 1385-1387
32. Lowry O.H., Rosenbrough N. J., Farr A. L. Randall R. J. (1951): Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275
33. Mclane M. P., Black P. R., Law W, R., Raymond R. M. (1990): Adenosine reversal of in vivo hepatic responsiveness to insulin. Diabetes 39, 62-69
34. Morrison P, D., Mackinnon M. W., Bartrup J. T., Skett P, G., Stone T. W. (1992): Changes in adenosine sensitivity in the hippocampus of rats with streptozotocin-induced diabetes. Br. J. Pharmacol. 105, 1004-1008
35. North C., Feuers R. J., Scheving L. E., Pauly J. E., Tsai T. H., Casciano D. A. (1981): Circadian organization of thirteen liver and six brain enzymes of the mouse. Am. J. Anat. 162, 183-199
36. Pawelczyk T., Sakowicz M., Szczepanska-Konkel M., Angielski S. (2000): Decreased expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats. Arch. Biochem. Biophys. 375, 1-6
37. Pelleg A., Porter R. S. (1990): The pharmacology of adenosine. Pharmacotheraphy 10, 157-174
38. Pflueger A. C., Schenk F., Osswald H. (1995): Increased sensitivity of the renal vasculature to adenosine in streptozotocin-induced diabetes mellitus rats. Am. J. Physiol. 269, 529-535
39. Rakieten N., Rakieten M. L. Nadkarni M. V. (1963): Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep. 29, 91-98
40. Rutkiewicz J., Gorski J. (1990): On the role of insulin in regulation of adenosine deaminase activity in rat tissues. FEBS Lett. 271, 79-80
41. Sands W. A., Palmer T. M. (2005): Adenosine receptors and the control of endothelial cell function in inflammatory disease. Immunol. Lett. 101, 1-11
42. Sawynok J., Liu X. J. (2003): Adenosine in the spinal cord and periphery: release and regulation of pain. Prog. Neurobiol. 69, 313-340
43. Schierwagen C., Bylund-Fellenius A. C., Lundberg C. (1990): improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J. Pharmacol. Methods 23, 179-186
44. Sener G., Kabasakal L., Sehirli O., Ercan F., Gedik N. (2006): 2-Mercaptoethane sulfonate (MESNA) protects against biliary obstruction-induced oxidative damage in rats. Hepatol. Res. 35, 140-146
45. Singh L. S., Sharma R. (1998): Alloxan diabetes regulates adenosine deaminase activity in mice: tissue- and age-specific correlation. Biochem. Mol. Biol. Int. 46, 55-61
46. Touitou Y., Haus E. (1994): Biologic Rhythms in Clinical and Laboratory Medicine (2nd printing), pp. 418-428, Springer-Verlag, Berlin, Heidelberg, New York
47. Touitou Y., Portaluppi F., Smolensky M. H., Rensing L. (2006): Ethics, standards, and procedures of animal and human chronobiology research. Chronobiol. Int. 23, 1083-1096
48. Tunon M. J., Gonzalez P., Lopez P., Salido G. M., Madrid J. A. (1992): Circadian rhythms in glutathione and glutathione-S-transferase activity of rat liver. Arch. Int. Physiol. Biochim. Biophys. 100, 83-87
49. Uchimura K., Nagasaka A., Hayashi R., Makino M., Nagata M., Kakizawa H., Kobayashi T., Fujiwara K., Kato T., Iwase K., Shinohara R., Kato K., Itoh M. (1999): Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus. J. Diabetes Complicat. 13, 264-270
50. Ulusu N. N., Ozbey G., Tandogan B., Gunes A., Durakoglugil D. B., Karasu C., Uluoglu C., Zengil H. (2005): Circadian variations in the activities of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in the liver of conrol and streptozotocin- induced diabetic rats. Chronobiol. Int. 22, 667-677
51. Watkins J. B., Sanders R. A. (1995): Diabetes mellitus-induced alterations of hepatobiliary function. Pharmacol. Rev. 47, 1-23
52. Weir G. C., Knowlton S. D., Martin D. B. (1975): Nucleotide and nucleoside stimulation of glucagon secretion. Endocrinology 97, 932-936
53. Wolf F., Cook G. H. (1977): Activation of steroidogenesis and adenylate cyclase by adenosine in adrenal and Leydig tumor cells. J. Biol. Chem. 252, 687-693
54. Zhang C., Yang J., Jennings L. K. (2004): Leukocyte-derived myeloperoxidase amplifies high-glucose-induced endothelial dysfunction through interaction with high-glucose-stimulated, vascular non-leukocyte-derived reactive oxygen species. Diabetes 53, 2950-2959